Irritable Bowel Syndrome
Irritable Bowel Syndrome
(Functional Colitis; IBS; Intestinal Neurosis; Irritable Colon; Laxative Colitis; Mucous Colitis; Nervous Indigestion; Spastic Colon)
- Family members with IBS
- Generalized anxiety disorder (associated with IBS)
- Abuse (may be associated with IBS)
- Abdominal cramps
- Gas and bloating
- Pain that resolves with a bowel movement
- Loose stools
- Alternating diarrhea and constipation
- Urge to move bowels again immediately following a bowel movement
- Mucus in the stool
- Menstrual periods
- Large meals or fatty foods
- Excess gas
- Stool tests
- Blood tests
|Copyright © Nucleus Medical Media, Inc.|
- Keep a food diary of what you eat and how your body responds. Share this with your doctor. You may have a food allergy.
- Make gradual changes to your diet. Record the results.
- Avoid foods that have caused problems in the past. A dietitian can help you substitute foods.
- Avoid foods and drinks that may cause symptoms:
- Eat foods that may reduce the chance of spasm, such as:
- Eat smaller meals more often or smaller portions.
- Eat slowly and try not to swallow air.
- Drink plenty of water. This will help to reduce constipation.
- Antispasmodic agent
- High-fiber bulking agent
- Antidiarrheal agent
- Low-dose antidepressant
- Pain reliever
- Serotonin receptor agonists and antagonists (also called 5-HT3 antagonists)—may be helpful for treating diarrhea, as well as treating other IBS symptoms, like abdominal pain in women
- Peppermint oil
American College of Gastroenterology http://gi.org
American Gastroenterological Association http://www.gastro.org
Canadian Digestive Health Foundation http://www.cdhf.ca
Health Canada http://www.hc-sc.gc.ca
Acidophilus and other probiotics. EBSCO Natural and Alternative Treatments website. Available at: http://www.ebscohost.com/healthLibrary/. Updated November 10, 2014. Accessed December 19, 2014.
Drossman DA. Treatment for bacterial overgrowth in the irritable bowel syndrome. Ann Intern Med. 2006;145:626-628.
Halvorson HA, Schlett CD, et al. Postinfectious irritable bowel syndrome—a meta-analysis. Am J Gastroenterol. 2006;101:1894-1899.
Irritable bowel syndrome. American Society of Colon and Rectal Surgeons website. Available at: http://www.fascrs.org/patients/conditions/irritable%5Fbowel%5Fsyndrome/. Update October 2012. Accessed December 19, 2014.
Irritable bowel syndrome. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated October 21, 2014. Accessed December 19, 2014.
Irritable bowel syndrome. National Institute of Diabetes and Digestive and Kidney Diseases website. Available at: http://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/ibs/Pages/facts.aspx. Updated June 25, 2014. Accessed December 19, 2014.
Murch S. Allergy and intestinal dysmotility—evidence of genuine causal linkage? Curr Opin Gastroenterol. 2006;22:664-668.
Rubin G, De Wit N, et al. The diagnosis of IBS in primary care: consensus development using nominal group technique. Family Practitioner. 2006;23:687-692.
Talley NJ, Boyce PM, et al. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study. Gut.1998;42: 47-53.
Yan F, Polk DB. Probiotics as functional food in the treatment of diarrhea. Current Opinion in Clinical Nutrition and Metabolic Care. 2006;9:717-721.
9/26/2006 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Mueller-Lissner S, Tytgat GN, et al. Placebo-and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain. Alimentary Pharmacology and Therapeutics. 2006;23:1741-1748.
4/10/2007 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: US Food and Drug Administration. FDA announces discontinued marketing of GI drug, Zelnorm, for safety reasons [press release]. March 30, 2007. US Food and Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108879.htm. Accessed December 19, 2014.
1/6/2009 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Ford AC, Talley NJ, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ . 2008;337:a2313.
10/9/2009 DynaMed Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Lee S, Wu J, et al. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Aliment Pharmacol Ther. 2009;30(6):643.
11/4/2009 DynaMed Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Ford AC, Brandt LJ, et al. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2009;104(7):1831-1843.
1/11/2010 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Wittmann T, Paradowski L, et al. Clinical trial: efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome: results of a randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2009 Dec 10. [Epub ahead of print]
7/16/2010 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Dorn SD. Systematic review: self-management support interventions for irritable bowel syndrome. Aliment Pharmacol Ther. 2010 May 22. [Epub ahead of print]
1/14/2011 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Pimentel M, Lembo A, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364(1):22-32.
4/22/2011 DynaMed's Systematic Literature Surveillance http://www.ebscohost.com/dynamed: Johannesson E, Simrén M, et al. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol. 2011 Jan 4. [Epub ahead of print]
- Reviewer: Daus Mahnke, MD
- Review Date: 12/2014 -
- Update Date: 12/20/2014 -